Dyne Therapeutics (DYN) Cash from Operations (2019 - 2026)

Dyne Therapeutics' Cash from Operations history runs 8 years deep, the most recent figure standing at 144922000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 36.86% year-over-year to 144922000.0; the TTM figure through Mar 2026 stood at 442236000.0 (down 38.32% YoY), while the FY2025 annual figure was 403207000.0, down 37.91% from the prior year.
• Cash from Operations was 144922000.0 for Q1 2026 at Dyne Therapeutics, down from 111832000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 29192000.0 in Q4 2022 to a low of 144922000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 69547117.65 across 5 years, with a median of 55642000.0 in 2023.
• Biggest YoY gain for Cash from Operations was 33.02% in 2022; the steepest drop was 175.86% in 2022.
• A 5-year view of Cash from Operations shows it stood at 29192000.0 in 2022, then retreated by 19.92% to 35006000.0 in 2023, then plunged by 140.92% to 84335000.0 in 2024, then sank by 32.6% to 111832000.0 in 2025, then dropped by 29.59% to 144922000.0 in 2026.
• The last three Cash from Operations figures came in at 144922000.0 (Q1 2026), 111832000.0 (Q4 2025), and 90779000.0 (Q3 2025), per Business Quant data.